Michael Weinmann

Bio

Michael Weinmann joined Capital Royalty in 2009 and opened the firm’s New York office. Mr. Weinmann has 11 years of capital markets and mergers and acquisitions experience, most recently as an Executive Director in Morgan Stanley’s Global Capital Markets division, specializing in structured debt financings and intellectual property monetizations. Mr. Weinmann was a co-developer of the Pharmaceutical Royalty Monetization Asset (royalty bond) product and structured and marketed the industry’s first 14 royalty bond transactions. Over the course of his career, Mr. Weinmann has been responsible for $3.4 billion of healthcare royalty monetizations. He joined Morgan Stanley in 1999 and had a leading role in the structuring of debt financings involving pharmaceutical royalties, infrastructure assets, aircraft, rolling stock, ships, power generation facilities, and real estate. 2010-Present - Johns Hopkins Homewood Technology Commercialization, Advisory Board. Mr. Weinmann received a Bachelor of Science in chemical engineering in 1999 from the Johns Hopkins University, graduating first in a class of 770.